Department of Traumatology, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
J Thorac Cardiovasc Surg. 2013 Nov;146(5):1041-6. doi: 10.1016/j.jtcvs.2012.08.022. Epub 2012 Sep 7.
Experience with extracorporeal membrane oxygenation for adult patients with refractory septic shock remains limited. We aimed to study the clinical features and outcomes of this patient group in an extracorporeal membrane oxygenation referral center in Taiwan.
From January 2005 to December 2010, all adult patients in refractory septic shock and requiring venoarterial extracorporeal membrane oxygenation for circulatory support were included in the present study. The variables analyzed included patient demographics; comorbidities; smoking status; hemodynamic, ventilatory, and laboratory parameters just before extracorporeal membrane oxygenation support; clinical course; extracorporeal membrane oxygenation details; complications; microbiology results; and outcomes. The primary endpoint was survival to hospital discharge.
A total of 52 patients, 39 men and 13 women, were included during a 6-year period. Their median age and body mass index was 56.8 years and 24.1 kg/m(2), respectively. Of the 52 patients, 39 (75%) had failure of at least 3 organ systems and 21 (40%) had developed cardiac arrest and received cardiopulmonary resuscitation at extracorporeal membrane oxygenation implantation. Of these 52 patients, 8 (15%) survived to hospital discharge. The nonsurvivors were significantly older than the survivors (59.3 vs 43.8 years; P = .009), and all 20 patients (38%) aged 60 years or older died.
In our single-center experience with extracorporeal membrane oxygenation for adults with refractory septic shock, the outcomes of these patients remain unsatisfactory. From our findings, we suggest that if extracorporeal membrane oxygenation were to be used in this patient population, age 60 years or older might be a contraindication. Also, central extracorporeal membrane oxygenation could possibly be beneficial according to the favorable pediatric experience in published studies.
成人难治性感染性休克患者体外膜氧合的经验仍然有限。我们旨在研究台湾一家体外膜氧合转介中心这一患者群体的临床特征和结局。
从 2005 年 1 月至 2010 年 12 月,所有因难治性感染性休克且需要静脉-动脉体外膜氧合以进行循环支持的成年患者均纳入本研究。分析的变量包括患者人口统计学特征;合并症;吸烟状况;体外膜氧合支持前的血流动力学、通气和实验室参数;临床病程;体外膜氧合详细信息;并发症;微生物学结果和结局。主要终点是存活至出院。
在 6 年期间共纳入 52 例患者,39 例男性和 13 例女性。他们的中位年龄和体重指数分别为 56.8 岁和 24.1kg/m2。52 例患者中,39 例(75%)至少有 3 个器官系统衰竭,21 例(40%)在体外膜氧合植入时发生心脏骤停并接受心肺复苏。这 52 例患者中,有 8 例(15%)存活至出院。非幸存者明显比幸存者年长(59.3 岁比 43.8 岁;P=0.009),所有 20 例(38%)年龄 60 岁或以上的患者均死亡。
在我们对成人难治性感染性休克患者进行体外膜氧合的单中心经验中,这些患者的结局仍然不理想。根据我们的研究结果,我们建议如果要在该患者人群中使用体外膜氧合,年龄 60 岁或以上可能是一个禁忌症。此外,根据已发表研究中有利的儿科经验,中央体外膜氧合可能是有益的。